Okay, let’s clarify the relationship between the CAN Risk Score and Diabetes Risk Assessment.

It’s crucial to understand that a CAN Risk Score is NOT a Diabetes Risk Assessment in the sense of predicting who will develop diabetes. Instead:

• The CAN Risk Score is an assessment of a specific complication of diabetes, namely Cardiac Autonomic Neuropathy (CAN).

• It’s used primarily for individuals who already have diabetes (or sometimes pre-diabetes) to assess their risk of this particular nerve damage affecting the heart.

Let me break it down:

What is Cardiac Autonomic Neuropathy (CAN)?

Cardiac Autonomic Neuropathy (CAN) is a serious and common long-term complication of diabetes. It occurs when the autonomic nerves that control the heart and blood vessels are damaged by chronically high blood sugar.

Key characteristics of CAN:

• Affects Heart Rate Regulation: Leads to a “fixed” heart rate, reducing Heart Rate Variability (HRV).

• Affects Blood Pressure Regulation: Can cause orthostatic hypotension (dizzy spells when standing up) or even hypertension.

• “Silent” Complication: Often asymptomatic in its early stages, making it dangerous.

• Serious Outcomes: Increases the risk of silent heart attacks, severe cardiovascular events, sudden cardiac death, and complications during surgery.

How a CAN Risk Score is Generated (using PPG, like RE.DOCTOR PediVitals)

As discussed, systems like RE.DOCTOR Pedivitals use smartphone-based Photoplethysmography (PPG) to derive a CAN Risk Score. Here’s a recap:

1. PPG Capture: User places a finger over the smartphone camera and flash.

2. Signal Analysis: The system captures the pulse waveform.

3. Biomarker Extraction:

   • Heart Rate Variability (HRV): The most critical marker. Reduced HRV signifies damage to the autonomic nerves controlling the heart.

   • Pulse Wave Morphology: Changes in the shape of the pulse wave can indicate arterial stiffness, which often co-occurs with CAN and diabetes.

4. AI Algorithm: Machine learning models, trained on clinical data, interpret these biomarkers.

5. CAN Risk Score: An algorithm calculates a score (e.g., Low, Moderate, High risk) indicating the likelihood and severity of CAN.

Relationship to Diabetes Risk Assessment

Here’s the critical distinction:

• Diabetes Risk Assessment: This typically involves tools like the FINDRISC questionnaire, blood tests (HbA1c, fasting glucose), and assessments of lifestyle factors (BMI, family history) to predict an individual’s likelihood of developing Type 2 Diabetes. It’s about prevention or early detection of diabetes itself.

• CAN Risk Score: This is a Diabetic Complication Assessment. It’s used:

  • For Individuals with Diabetes: To monitor their cardiac health and detect CAN early, allowing for interventions to slow its progression and manage associated risks. Early detection of CAN can lead to more aggressive management of blood glucose, blood pressure, and lipids.

  • For Individuals with Pre-diabetes (Less Common but Emerging): Some research suggests that early signs of autonomic dysfunction can appear even in pre-diabetes. A CAN risk score in this group might indicate a higher risk of progressing to full diabetes and developing complications earlier. However, this application is less common than for diagnosed diabetics.

  Think of it this way:

  • Diabetes Risk Assessment: “Are you likely to get the disease?”

  • CAN Risk Score: “If you have the disease (or are heading towards it), how is it affecting your heart’s nervous system?”

In summary, a CAN Risk Score is a tool to assess and manage a specific, serious complication within the context of diabetes, not a primary tool to predict the onset of diabetes itself. It serves as an important early warning system for heart-related nerve damage in diabetic individuals.